Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chemoembolization of hepatocellular carcinoma with HepaSphere 30-60 μm. Safety and efficacy study.
Malagari K, Pomoni M, Moschouris H, Kelekis A, Charokopakis A, Bouma E, Spyridopoulos T, Chatziioannou A, Sotirchos V, Karampelas T, Tamvakopoulos C, Filippiadis D, Karagiannis E, Marinis A, Koskinas J, Kelekis DA. Malagari K, et al. Among authors: tamvakopoulos c. Cardiovasc Intervent Radiol. 2014 Feb;37(1):165-75. doi: 10.1007/s00270-013-0777-x. Epub 2013 Nov 22. Cardiovasc Intervent Radiol. 2014. PMID: 24263774 Free PMC article.
Transarterial embolization with sorafenib in animal livers: a pharmacokinetics study.
Chatziioannou AN, Siskos AP, Loxas D, Kavatzas N, Agrogiannis G, Fokas D, Malagari K, Kostomitsopoulos NG, Tsigkou O, Tamvakopoulos C. Chatziioannou AN, et al. Among authors: tamvakopoulos c. J Vasc Interv Radiol. 2013 Nov;24(11):1657-63.e1. doi: 10.1016/j.jvir.2013.08.007. Epub 2013 Sep 21. J Vasc Interv Radiol. 2013. PMID: 24060438
Versatile quarto stimuli nanostructure based on Trojan Horse approach for cancer therapy: Synthesis, characterization, in vitro and in vivo studies.
Efthimiadou EK, Fragogeorgi E, Palamaris L, Karampelas T, Lelovas P, Loudos G, Tamvakopoulos C, Kostomitsopoulos N, Kordas G. Efthimiadou EK, et al. Among authors: tamvakopoulos c. Mater Sci Eng C Mater Biol Appl. 2017 Oct 1;79:605-612. doi: 10.1016/j.msec.2017.05.082. Epub 2017 May 13. Mater Sci Eng C Mater Biol Appl. 2017. PMID: 28629059
GnRH-Gemcitabine conjugates for the treatment of androgen-independent prostate cancer: pharmacokinetic enhancements combined with targeted drug delivery.
Karampelas T, Argyros O, Sayyad N, Spyridaki K, Pappas C, Morgan K, Kolios G, Millar RP, Liapakis G, Tzakos AG, Fokas D, Tamvakopoulos C. Karampelas T, et al. Among authors: tamvakopoulos c. Bioconjug Chem. 2014 Apr 16;25(4):813-23. doi: 10.1021/bc500081g. Epub 2014 Apr 3. Bioconjug Chem. 2014. PMID: 24661240
Design, synthesis and biological evaluation of novel substituted purine isosters as EGFR kinase inhibitors, with promising pharmacokinetic profile and in vivo efficacy.
Gavriil ES, Doukatas A, Karampelas T, Myrianthopoulos V, Dimitrakis S, Mikros E, Marakos P, Tamvakopoulos C, Pouli N. Gavriil ES, et al. Among authors: tamvakopoulos c. Eur J Med Chem. 2019 Aug 15;176:393-409. doi: 10.1016/j.ejmech.2019.05.029. Epub 2019 May 8. Eur J Med Chem. 2019. PMID: 31125894
64 results